Analyst Rating Changes — Upgrades, Downgrades & Price Targets

30196 recent Wall Street rating changes — with our own star rating shown next to every analyst we independently track.

Track the latest analyst rating changes from Wall Street brokerages: stock upgrades, downgrades and price-target revisions, updated through the day. Unlike a plain ratings feed, every change here is matched — where we can — to the analyst's independent track record on 13Foresight, so you can see at a glance whether the person behind the call has actually been accurate. Analysts we rank show a ★★★★☆ score and link to their full performance page; firms link to their pooled track record. Use the tabs below to filter by change type.

All ↑ Upgrades ↓ Downgrades ◎ Price Targets

Latest Price-Target Changes

When	Stock	Change	Firm	Analyst	Rating	Price Target
Oct 02 00:00 UTC	WIL Wilmington	◎ Target	Canaccord Genuity Group	firm only	Buy	GBX 445→ GBX 470+5.6%
Oct 02 00:00 UTC	WGS GeneDx	◎ Target	Guggenheim	Subbu Nambi ★★★★★ #296	Buy	$74.00→ $83.00+12.2%
Oct 02 00:00 UTC	WFC Wells Fargo & Company	◎ Target	Truist Financial	John McDonald not yet tracked	Buy	$94.00→ $95.00+1.1%
Oct 02 00:00 UTC	WAT Waters	◎ Target	Guggenheim	Subbu Nambi ★★★★★ #296	Buy	$440.00→ $490.00+11.4%
Oct 02 00:00 UTC	WAL Western Alliance Bancorporation	◎ Target	JPMorgan Chase & Co.	Anthony Elian ★★☆☆☆ #2302	Neutral	$93.00→ $90.00-3.2%
Oct 02 00:00 UTC	WAFD WaFd	◎ Target	Piper Sandler	Matthew Clark ★★★★☆ #793	Neutral	$36.00→ $32.00-11.1%
Oct 02 00:00 UTC	VVV Valvoline	◎ Target	Citigroup	Steven Zaccone ★★★☆☆ #1789	Neutral	$41.00→ $34.00-17.1%
Oct 02 00:00 UTC	VLY Valley National Bancorp	◎ Target	JPMorgan Chase & Co.	Anthony Elian ★★☆☆☆ #2302	Overweight	$17.00→ $15.50-8.8%
Oct 02 00:00 UTC	VICR Vicor	◎ Target	Needham & Company LLC	N. Quinn Bolton not yet tracked	Buy	$320.00→ $350.00+9.4%
Oct 02 00:00 UTC	USB U.S. Bancorp	◎ Target	Truist Financial	John McDonald not yet tracked	Buy	$69.00→ $67.00-2.9%
Oct 02 00:00 UTC	UMBF UMB Financial	◎ Target	JPMorgan Chase & Co.	Anthony Elian ★★☆☆☆ #2302	Overweight	$180.00→ $160.00-11.1%
Oct 02 00:00 UTC	TWST Twist Bioscience	◎ Target	Guggenheim	Subbu Nambi ★★★★★ #296	Buy	$107.00→ $212.00+98.1%
Oct 02 00:00 UTC	TWFG TWFG	◎ Target	JPMorgan Chase & Co.	Pablo Singzon ★★★☆☆ #1190	Neutral	$28.00→ $26.00-7.1%
Oct 02 00:00 UTC	TEM Tempus AI	◎ Target	Guggenheim	Subbu Nambi ★★★★★ #296	Buy	$65.00→ $92.00+41.5%
Oct 02 00:00 UTC	TCBK TriCo Bancshares	◎ Target	Piper Sandler	Matthew Clark ★★★★☆ #793	Neutral	$63.00→ $56.50-10.3%
Oct 02 00:00 UTC	TCBI Texas Capital Bancshares	◎ Target	JPMorgan Chase & Co.	Anthony Elian ★★☆☆☆ #2302	Underweight	$110.00→ $100.00-9.1%
Oct 02 00:00 UTC	SWKS Skyworks Solutions	◎ Target	Royal Bank Of Canada	Srini Pajjuri ★★★☆☆ #1235	Sec→ r Perform	$70.00→ $95.00+35.7%
Oct 02 00:00 UTC	SSRM SSR Mining	◎ Target	ATB Cormark Capital Markets	firm only	Outperform	C$59.00→ C$64.00+8.5%
Oct 02 00:00 UTC	SSB SouthState Bank	◎ Target	JPMorgan Chase & Co.	Anthony Elian ★★☆☆☆ #2302	Overweight	$125.00→ $120.00-4.0%
Oct 02 00:00 UTC	SPOT Spotify Technology	◎ Target	KeyCorp	Justin Patterson ★★★★☆ #669	Overweight	$680.00→ $660.00-2.9%
Oct 02 00:00 UTC	SOLS Solstice Advanced Mat	◎ Target	Mizuho	John Roberts not yet tracked	Neutral	$70.00→ $65.00-7.1%
Oct 02 00:00 UTC	SNPS Synopsys	◎ Target	KeyCorp	Jason Celino ★★★★☆ #704	Overweight	$600.00→ $605.00+0.8%
Oct 02 00:00 UTC	SNPS Synopsys	◎ Target	Wells Fargo & Company	Joe Quatrochi not yet tracked	Overweight	$475.00→ $540.00+13.7%
Oct 02 00:00 UTC	SNPS Synopsys	◎ Target	Rosenblatt Securities	Blair Abernethy ★★★☆☆ #1674	Buy	$575.00→ $620.00+7.8%
Oct 02 00:00 UTC	SMTC Semtech	◎ Target	Oppenheimer	Rick Schafer ★★★☆☆ #1322	Outperform	$200.00→ $225.00+12.5%
Oct 02 00:00 UTC	SMMT Summit Therapeutics	◎ Target	Barclays	Etzer Darout ★★★☆☆ #2220	Equal Weight	$18.00→ $20.00+11.1%
Oct 02 00:00 UTC	SGMT Sagimet Biosciences	◎ Target	Oppenheimer	Jay Olson ★★★★☆ #357	Outperform	$33.00→ $38.00+15.2%
Oct 02 00:00 UTC	SGMT Sagimet Biosciences	◎ Target	Citizens Jmp	Jonathan Wolleben ★★★★★ #152	Market Outperform	$29.00→ $27.00-6.9%
Oct 02 00:00 UTC	SARO StandardAero	◎ Target	Susquehanna	Charles Minervino ★★★★★ #284	Positive	$37.00→ $34.00-8.1%
Oct 02 00:00 UTC	SAGA Saga	◎ Target	Deutsche Bank Aktiengesellschaft	firm only	Buy	GBX 795→ GBX 855+7.5%
Oct 02 00:00 UTC	ROG Rogers	◎ Target	B. Riley Financial	Craig Ellis ★★★★☆ #903	Buy	$200.00→ $225.00+12.5%
Oct 02 00:00 UTC	RKT Reckitt Benckiser Group	◎ Target	Jefferies Financial Group	firm only	Buy	GBX 6,100→ GBX 5,900-3.3%
Oct 02 00:00 UTC	REGN Regeneron Pharmaceuticals	◎ Target	Jefferies Financial Group	Akash Tewari ★★★☆☆ #1116	Buy	$870.00→ $930.00+6.9%
Oct 02 00:00 UTC	Q Qnity Electronics	◎ Target	Mizuho	John Roberts not yet tracked	Outperform	$180.00→ $160.00-11.1%
Oct 02 00:00 UTC	PRQR ProQR Therapeutics	◎ Target	HC Wainwright	Ananda Ghosh ★★★☆☆ #2060	Buy	$8.00
Oct 02 00:00 UTC	PNW Pinnacle West Capital	◎ Target	Barclays	Nicholas Campanella ★★★★★ #295	Equal Weight	$108.00→ $94.00-13.0%
Oct 02 00:00 UTC	PNFP Pinnacle Financial Partners	◎ Target	JPMorgan Chase & Co.	Anthony Elian ★★☆☆☆ #2302	Overweight	$120.00→ $115.00-4.2%
Oct 02 00:00 UTC	PNC The PNC Financial Services Group	◎ Target	Truist Financial	John McDonald not yet tracked	Hold	$264.00→ $252.00-4.5%
Oct 02 00:00 UTC	PJT PJT Partners	◎ Target	The Goldman Sachs Group	James Yaro ★★★☆☆ #2238	Buy	$203.00→ $182.00-10.3%
Oct 02 00:00 UTC	PFBC Preferred Bank	◎ Target	Piper Sandler	Matthew Clark ★★★★☆ #793	Overweight	$115.00→ $120.00+4.3%
Oct 02 00:00 UTC	PEBO Peoples Bancorp	◎ Target	DA Davidson	Jeff Rulis ★★★★☆ #360	Buy	$44.00→ $42.00-4.5%
Oct 02 00:00 UTC	OOMA Ooma	◎ Target	Freedom Broker	Saken Ismailov ★★★☆☆ #1814	Buy	$24.00→ $25.00+4.2%
Oct 02 00:00 UTC	ONON ON	◎ Target	JPMorgan Chase & Co.	Wendy Liu not yet tracked	Overweight	$41.00→ $44.00+7.3%
Oct 02 00:00 UTC	ONC BeOne Medicines	◎ Target	JPMorgan Chase & Co.	Jessica Fye ★☆☆☆☆ #2951	Overweight	$425.00→ $445.00+4.7%
Oct 02 00:00 UTC	ONB Old National Bancorp	◎ Target	JPMorgan Chase & Co.	Anthony Elian ★★☆☆☆ #2302	Overweight	$32.00→ $30.00-6.2%
Oct 02 00:00 UTC	OLN Olin	◎ Target	Wells Fargo & Company	Abigail Eberts not yet tracked	Equal Weight	$20.00→ $16.00-20.0%
Oct 02 00:00 UTC	NTRA Natera	◎ Target	Guggenheim	Subbu Nambi ★★★★★ #296	Buy	$360.00→ $475.00+31.9%
Oct 02 00:00 UTC	NBHC National Bank	◎ Target	Piper Sandler	Matthew Clark ★★★★☆ #793	Overweight	$51.00→ $49.00-3.9%
Oct 02 00:00 UTC	MU Micron Technology	◎ Target	Rosenblatt Securities	Kevin Cassidy ★★★★☆ #858	Buy	$1,500.00→ $1,900.00+26.7%
Oct 02 00:00 UTC	MU Micron Technology	◎ Target	DA Davidson	Gil Luria ★★★★☆ #918	Buy	$2,000.00→ $2,100.00+5.0%

🔒 38 more rating changes on this page — plus filtering by our own analyst accuracy.

A free account unlocks the full daily feed.

Frequently Asked Questions

What are analyst rating changes?

An analyst rating change is when a Wall Street brokerage updates its recommendation on a stock — an upgrade (e.g. Hold → Buy), a downgrade (e.g. Buy → Sell), or a price-target revision (raising or lowering the expected share price). This page lists the most recent changes across U.S. markets.

How is this feed different from other rating trackers?

Where we independently track the analyst, each change shows our own star rating and accuracy rank, computed from real historical price performance — not the brokerage's own marketing. That lets you judge whether the analyst behind a call has actually been right before.

How often is the rating-changes feed updated?

The feed refreshes several times a day, so new upgrades, downgrades and price-target changes appear the same day they are published. Each row shows the date and time we recorded it.

Do analyst upgrades and price-target increases mean I should buy?

No. A rating change is one analyst's opinion, not investment advice. Track records vary widely — which is exactly why we attach each analyst's independent accuracy. Always do your own research.

Analyst Rating Changes — Upgrades, Downgrades & Price Targets

Latest Price-Target Changes

Frequently Asked Questions

Welcome to 13Foresight!